All Stories

Quest Diagnostics taps MD Anderson for cancer risk blood test

Dubbed the multi-cancer stratification test, or MCaST, Quest said it may help identify people who could benefit from more frequent screenings.

Jun 10, 2025 - 20:20
 0
Quest Diagnostics taps MD Anderson for cancer risk blood test
Dubbed the multi-cancer stratification test, or MCaST, Quest said it may help identify people who could benefit from more frequent screenings.
Read More

Tags:

Previous Article

'All innuendo and conspiracy'—RFK Jr.'s vaccine advisory overhaul undermines vac...

Next Article

STAT+: AMA takes on new billing codes for AI, and Omada execs on IPO

Related Posts

Study unpacks ‘new realm of biology,’ where missing Y chromosomes worsen cancer outcomes

Study unpacks ‘new realm of biology,’ where missing Y c...

Jun 6, 2025  0

Merus hails 'unprecedented' survival on solid tumor bispecific, sparking stock jump

Merus hails 'unprecedented' survival on solid tumor bis...

May 23, 2025  0

Erasca enters another era, seeks partner for ph. 3 ex-Novartis asset

Erasca enters another era, seeks partner for ph. 3 ex-N...

May 13, 2025  0